Gahee Park (@loki_phd) 's Twitter Profile
Gahee Park

@loki_phd

🇨🇦🇺🇸🇰🇷🇬🇧 SNU PhD | @Cambridge_Uni former Postdoc |
Biomedical Data Scientist @Lunit_AI

Interested in early detection of cancer using AI and cfDNA

ID: 827550221332680704

linkhttps://www.linkedin.com/in/gahee-park-64b23b56 calendar_today03-02-2017 16:12:02

242 Tweet

153 Followers

284 Following

Alex Wyatt (@researchwyatt) 's Twitter Profile Photo

Here’s our nature paper on v deep whole-genome sequencing of serial ctDNA and met tissue. @cherberts1, Matti, Joonatan et al applied new methods to give fascinating insight into temporal #ProstateCancer clonal complexity and evolution of resistance. 1/7 nature.com/articles/s4158…

Here’s our <a href="/Nature/">nature</a> paper on v deep whole-genome sequencing of serial ctDNA and met tissue. @cherberts1, Matti, Joonatan et al applied new methods to give fascinating insight into temporal #ProstateCancer clonal complexity and evolution of resistance. 1/7 nature.com/articles/s4158…
Lunit (@lunit_ai) 's Twitter Profile Photo

🎊We did it!🎊 As of today, #Lunit is officially a #public company listed on the KOSDAQ market! We want to express our most sincere gratitude for all of your support. Here's to the new heights we'll reach in our endless journey ahead!🚀 ✔️Read more: bit.ly/3opiYBC

🎊We did it!🎊

As of today, #Lunit is officially a #public company listed on the KOSDAQ market!

We want to express our most sincere gratitude for all of your support.

Here's to the new heights we'll reach in our endless journey ahead!🚀

✔️Read more: bit.ly/3opiYBC
Lunit (@lunit_ai) 's Twitter Profile Photo

At #Lunit, we're taking every opportunity to accelerate research on #AI biomarkers. Lunit SCOPE IO was featured in a new #clinical trial on combination #immunotherapy for nasopharyngeal cancer. The study has been published in Clinical Cancer Research. ✔️Read more ⬇️ bit.ly/3oICYiP

Massie_Lab (@massie_lab) 's Twitter Profile Photo

An exciting opportunity to join our dynamic teams as part of an international collaboration on leading-edge methods for cell-free DNA methylation assays to facilitate effective cancer early detection: jobs.cam.ac.uk/job/36196/

Florent Mouliere (@florentmouliere) 's Twitter Profile Photo

Interested in cell-free DNA and #liquidbiopsy? Want a ride to catch up on the recent progress related to the biology of #cfDNA? Ask for hitchhiking! Here is our new review: A hitchhiker’s guide to cell-free DNA biology academic.oup.com/noa/article/4/…

Dan Landau (@landau_lab) 's Twitter Profile Photo

🔥Extra-hot pre-print before this hellsite goes up in smoke 🔥 New horizons open up when sequencing costs go ↘️ Ultima Genomics Interested in deep cfDNA WGS for ultra-sensitive cancer detection? Duplex sequencing at genome scale? biorxiv.org/content/10.110… Check out 🪡👇

Woody Zhidong ZHANG (@dnarna88) 's Twitter Profile Photo

Welcome to read & comment on this preprint about cell-free DNA fragmentomic patterns (preferred ends, coverage profile, and size profile) in capture-based low-pass seq data. We found that it is possible to detect cfDNA hydroxymethylation and fragmentomic markers simultaneously

Alex Aravanis MD PhD (@alex_aravanis) 's Twitter Profile Photo

Congrats to University of Jerusalem, GRAIL, and @Illumina teams on the world’s most comprehensive atlas of human cell type methylomes, revealing thousands of #methylation sites. It was a personal privilege to contribute to this foundational science. nature.com/articles/s4158…

Early Cancer Institute, University of Cambridge (@earlycancercam) 's Twitter Profile Photo

📢We are hiring!📢 Come and join our vibrant, collaborative and innovative team. We are looking for exceptional researchers, ready to develop their careers and build ambitious, independent research programmes. 🗓️CLOSING DATE: 13 March 2023 earlycancer.cam.ac.uk/jobs/junior-gr…

📢We are hiring!📢
Come and join our vibrant, collaborative and innovative team.
We are looking for exceptional researchers, ready to develop their careers and build ambitious, independent research programmes.
🗓️CLOSING DATE: 13 March 2023
earlycancer.cam.ac.uk/jobs/junior-gr…
Guardant Health (@guardanthealth) 's Twitter Profile Photo

We’re thrilled to introduce Guardant Galaxy, a suite of advanced AI analytics to enhance our test performance, starting with AI-backed image analysis developed by Lunit to improve PD-L1 #biomarker detection in patients with NSCLC. bit.ly/3kPKU37

We’re thrilled to introduce Guardant Galaxy, a suite of advanced AI analytics to enhance our test performance, starting with AI-backed image analysis developed by <a href="/Lunit_AI/">Lunit</a> to improve PD-L1 #biomarker detection in patients with NSCLC. 
bit.ly/3kPKU37
David B. Solit, MD (@dsolit) 's Twitter Profile Photo

The prospective clinical MSK-IMPACT/MSK-ACCESS cohort is now >100,000 tumor/cfDNA samples sequenced. Thanks to the thousands of physicians, nurses, technicians, data/computational scientists, engineers, and staff Memorial Sloan Kettering Cancer Center who have made this possible. A few thoughts:

The prospective clinical MSK-IMPACT/MSK-ACCESS cohort is now &gt;100,000 tumor/cfDNA samples sequenced. Thanks to the thousands of physicians, nurses, technicians, data/computational scientists, engineers, and staff <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> who have made this possible. A few thoughts:
Christopher G. Smith (@chris_g_smith1) 's Twitter Profile Photo

Woo hoo - check out this publication from our friends at the NKI, exploring neoadj ipi+nivo in urotherlial cancer patients, AND presence of cf tumour DNA, as assessed by RaDaR, in urine and plasma! NeoGenomics Inivata nature.com/articles/s4159…

Early Cancer Institute, University of Cambridge (@earlycancercam) 's Twitter Profile Photo

Our Early Cancer Institute team are running in memory of our dear colleague Charlie Massie Massie_Lab Please donate to our #RaceforLife and together we will beat cancer fundraise.cancerresearchuk.org/team/early-can…

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types bit.ly/3uyxVbm Jeanne Shen MD Gahee Park

New #JITC article: Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types bit.ly/3uyxVbm <a href="/jeanne_shen/">Jeanne Shen MD</a> <a href="/loki_phd/">Gahee Park</a>
Gahee Park (@loki_phd) 's Twitter Profile Photo

Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer Massie_Lab Early Cancer Institute, University of Cambridge University of Melbourne sciencedirect.com/science/articl…